Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Ecco i finalisti del Premio Roma di letteratura - Il Faro Online
American Association for Cancer Research • 97th Annual Meeting 1 ...
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Giancarlo Antonini (@gcarloantonini) / Twitter
Giancarlo Antonini (@gcarloantonini) / Twitter
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Genomic Classification of Cutaneous Melanoma - University of Miami
ioo;;-~~ ." - ,
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
PDF] Mutational Profile of Driver Genes in Brazilian Melanomas by Anna Luiza Silva Almeida Vicente, Camila Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui L. Reis, Vinicius de Lima Vazquez · OA.mg · 10.1200/jgo.19.00169
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.